Clinical Trial Update: A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED) [Phase 1]

View source ↗

Summary

A Phase 1 study of MK0731 in patients with advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• MK0731

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cancer | Phase 1 | Status: COMPLETED